SARS-CoV-2 characterized ePBMC®

We offer PBMC from subjects who verifiably have or have not been infected by SARS-CoV-2.

Product 1 – Subjects collected in the Pre-COVID era (11/2019) that are immunologically uncharacterized (negative controls)

Cat# CTL-PCOV-UP1
≥10 million cells per vial
$ 192/vial

Product 2 – Subjects with prior (PCR-verified) infection with SARS-CoV-2, collected after convalescence and characterized for T and/or B cell reactivity against SARS-CoV-2 antigens (positive controls)

Cat# CTL-PCOV-CP2
≥10 million cells per vial
$ 560/vial

Product 3 – Subjects collected in the Post-COVID era that exhibit memory B cell reactivity against SARS-CoV-2 Nucleocapsid or Spike antigens, suggesting past SARS-CoV-2 infection. (see reference)

Cat# CTL-PCOV-CP3
≥10 million cells per vial
$ 360/vial

For custom concentrations and volume discounts, please inquire at pbmc@immunospot.com


More Information

Details

These cryopreserved PBMC are ideal for any applications that requires samples from subjects who verifiably have or have not been infected by SARS-CoV-2.